Patient Guide: Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 348 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06890598
Status: 🟢 Enrolling Now
Condition: Carcinoma, Non-Small-Cell Lung
Phase: PHASE3

Where You Can Participate

This study is available at 348 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Huntsville, Alabama
  • • Tucson, Arizona
  • • And 345 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer - Join Clinical Trial NCTNCT06890598

How to Join This Clinical Trial - NCTNCT06890598

Learn how to participate in this PHASE3 trial studying an investigational therapy for Carcinoma, Non-Small-Cell Lung. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Carcinoma, Non-Small-Cell Lung. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Carcinoma, Non-Small-Cell Lung
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06890598 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 348 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35294-3300 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Huntsville, Alabama 35805 - United States

Status: RECRUITING

Clinical Research Site

Tucson, Arizona 85719 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Springdale, Arkansas 72762 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90404 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Oceanside, California 92056 - United States

Status: RECRUITING

Clinical Research Site

Orange, California 92868 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Palo Alto, California 94304 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

San Diego, California 92108 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Walnut Creek, California 94598 - United States

Status: NOT_YET_RECRUITING

And 338 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Carcinoma, Non-Small-Cell Lung:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships